Funding · Company
ADARx Pharmaceuticals, Inc.
San Diego, CABiotech & Pharma
ADARx Pharmaceuticals, Inc. of San Diego, CA has disclosed $321M across 3 Form D offerings filed with the SEC between Aug 17, 2021 and Aug 10, 2023.
$321M
Total disclosed
3
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersSan Diego, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001802369Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →